Literature DB >> 20560817

Association between the FCGR3A V158F polymorphism and the clinical response to infliximab in rheumatoid arthritis and spondyloarthritis patients.

M J Morales-Lara, P Conesa-Zamora, M S García-Simón, F Pedrero, V Santaclara, M Perez-Guillermo, E Soriano-Navarro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20560817     DOI： 10.3109/03009741003781969

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN： 0300-9742            Impact factor:   3.641


× No keyword cloud information.
  11 in total

1.  The -308 TNFα and the -174 IL-6 promoter polymorphisms associate with effective anti-TNFα treatment in seronegative spondyloarthritis.

Authors:  M Fabris; L Quartuccio; C Fabro; S Sacco; S Lombardi; R Ramonda; D Biasi; D Punzi; S Adami; I Olivieri; F Curcio; S De Vita
Journal:  Pharmacogenomics J       Date:  2015-07-07       Impact factor: 3.550

2.  Functional FCGR3A 158 V/F and IL-6 -174 C/G polymorphisms predict response to biologic therapy in patients with rheumatoid arthritis: a meta-analysis.

Authors:  Young Ho Lee; Sang-Cheol Bae; Gwan Gyu Song
Journal:  Rheumatol Int       Date:  2014-04-12       Impact factor: 2.631

Review 3.  Pharmacogenetics of treatment response in psoriatic arthritis.

Authors:  Meghna Jani; Anne Barton; Pauline Ho
Journal:  Curr Rheumatol Rep       Date:  2015-07       Impact factor: 4.592

Review 4.  Toward Overcoming Treatment Failure in Rheumatoid Arthritis.

Authors:  Zhuqian Wang; Jie Huang; Duoli Xie; Dongyi He; Aiping Lu; Chao Liang
Journal:  Front Immunol       Date:  2021-12-23       Impact factor: 7.561

5.  Gene Ontology Analysis Highlights Biological Processes Influencing Non-Response to Anti-TNF Therapy in Rheumatoid Arthritis.

Authors:  Gregor Jezernik; Mario Gorenjak; Uroš Potočnik
Journal:  Biomedicines       Date:  2022-07-27

6.  Macrophages in synovial inflammation.

Authors:  Aisling Kennedy; Ursula Fearon; Douglas J Veale; Catherine Godson
Journal:  Front Immunol       Date:  2011-10-10       Impact factor: 7.561

7.  Ankylosing spondylitis: from cells to genes.

Authors:  José Francisco Zambrano-Zaragoza; Juan Manuel Agraz-Cibrian; Christian González-Reyes; Ma de Jesús Durán-Avelar; Norberto Vibanco-Pérez
Journal:  Int J Inflam       Date:  2013-07-21

8.  RADB: a database of rheumatoid arthritis-related polymorphisms.

Authors:  Ruijie Zhang; Meiwei Luan; Zhenwei Shang; Lian Duan; Guoping Tang; Miao Shi; Wenhua Lv; Hongjie Zhu; Jin Li; Hongchao Lv; Mingming Zhang; Guiyou Liu; He Chen; Yongshuai Jiang
Journal:  Database (Oxford)       Date:  2014-09-15       Impact factor: 3.451

9.  Predictors of response to TNF antagonists in patients with ankylosing spondylitis and psoriatic arthritis: systematic review and meta-analysis.

Authors:  Jose Ramon Maneiro; Alejandro Souto; Eva Salgado; Antonio Mera; Juan J Gomez-Reino
Journal:  RMD Open       Date:  2015-02-18

10.  A FCGR3A Polymorphism Predicts Anti-drug Antibodies in Chronic Inflammatory Bowel Disease Patients Treated With Anti-TNF.

Authors:  Patricia Romero-Cara; Daniel Torres-Moreno; José Pedregosa; Juan Antonio Vílchez; María Sergia García-Simón; Guadalupe Ruiz-Merino; Senador Morán-Sanchez; Pablo Conesa-Zamora
Journal:  Int J Med Sci       Date:  2018-01-01       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.